患有和未患有糖尿病的慢性肾衰竭患者的血浆脂蛋白(a)水平。 - Suppr | 超能文献

Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus.

作者信息

Makino K, Josephson M A, Fellner S K, Scanu A M

出版信息

Atherosclerosis. 1993 Jan 25;98(2):255-6. doi: 10.1016/0021-9150(93)90136-i.

DOI:10.1016/0021-9150(93)90136-i

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus.患有和未患有糖尿病的慢性肾衰竭患者的血浆脂蛋白(a)水平。

Atherosclerosis. 1993 Jan 25;98(2):255-6. doi: 10.1016/0021-9150(93)90136-i.

2

Levels of plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis are not related to peritoneal losses of albumin.持续性非卧床腹膜透析患者的血浆脂蛋白(a)水平与白蛋白的腹膜丢失无关。

Nephron. 1997;76(2):239-41. doi: 10.1159/000190181.

3

[Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].[血浆果糖胺在非糖尿病和糖尿病慢性肾衰竭中的价值]

Presse Med. 1989 Nov 4;18(36):1781-4.

4

Plasma carnitine levels in patients undergoing hemodialysis.接受血液透析患者的血浆肉碱水平

Nephron. 1998 Sep;80(1):87-8. doi: 10.1159/000045135.

5

Blood levels of chromium in diabetic and nondiabetic hemodialysis patients.糖尿病和非糖尿病血液透析患者的血液铬水平。

Transplant Proc. 1996 Dec;28(6):3382-4.

6

Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.

Proc Eur Dial Transplant Assoc. 1983;19:221-6.

7

Peritoneal dialysis for patients with diabetes and end-stage renal disease: sorting out the biases?糖尿病合并终末期肾病患者的腹膜透析：消除偏差？

ASAIO J. 1996 Jan-Feb;42(1):1-3.

8

Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin?糖尿病透析患者血糖控制的评估：糖化血红蛋白还是糖化白蛋白？

Clin J Am Soc Nephrol. 2011 Jul;6(7):1520-2. doi: 10.2215/CJN.04210511.

9

Effects of two different dialytic treatments on inflammatory markers in people with end-stage renal disease with and without type 2 diabetes mellitus.两种不同透析治疗对终末期肾病合并或不合并2型糖尿病患者炎症标志物的影响。

Cytokine. 2017 Apr;92:75-79. doi: 10.1016/j.cyto.2016.12.026. Epub 2017 Jan 18.

10

Type 1 and type 2 diabetes and renal replacement therapy.1型和2型糖尿病与肾脏替代治疗。

Diabet Med. 1989 Jan-Feb;6(1):86. doi: 10.1111/j.1464-5491.1989.tb01146.x.

引用本文的文献

1

Relationship between lipoprotein (a) and micro/macro complications in type 2 diabetes mellitus: a forgotten target.2型糖尿病中脂蛋白(a)与微血管/大血管并发症之间的关系：一个被遗忘的靶点。

J Geriatr Cardiol. 2015 Mar;12(2):93-9. doi: 10.11909/j.issn.1671-5411.2015.02.001.